BRAF and melanoma: Moreover, paradoxical MAPK activation, induced by BRAF inhibitors in genetically “normal” stromal cells, promotes a “therapy-resistant” microenvironment: Intravital imaging analyses conducted in melanoma have shown major paradox MAPK reactivation, especially in areas with high stromal density.